MOBILEYE GLOBAL INC-A (MBLY)

US60741F1049 - Common Stock

28.58  +0.08 (+0.28%)

After market: 28.3563 -0.22 (-0.78%)

Fundamental Rating

5

MBLY gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 43 industry peers in the Automobile Components industry. No worries on liquidiy or solvency for MBLY as it has an excellent financial health rating, but there are worries on the profitability. MBLY is valied quite expensively at the moment, while it does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

MBLY had positive earnings in the past year.
MBLY had a positive operating cash flow in the past year.
In the past 5 years MBLY always reported negative net income.
Each year in the past 5 years MBLY had a positive operating cash flow.

1.2 Ratios

MBLY has a Return On Assets of -1.08%. This is in the lower half of the industry: MBLY underperforms 64.29% of its industry peers.
MBLY has a Return On Equity of -1.12%. This is comparable to the rest of the industry: MBLY outperforms 42.86% of its industry peers.
Industry RankSector Rank
ROA -1.08%
ROE -1.12%
ROIC N/A
ROA(3y)-0.38%
ROA(5y)N/A
ROE(3y)-0.4%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of MBLY (48.06%) is better than 97.62% of its industry peers.
In the last couple of years the Gross Margin of MBLY has grown nicely.
MBLY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

MBLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
MBLY has more shares outstanding than it did 1 year ago.
There is no outstanding debt for MBLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 24.07 indicates that MBLY is not in any danger for bankruptcy at the moment.
MBLY has a Altman-Z score of 24.07. This is amongst the best in the industry. MBLY outperforms 100.00% of its industry peers.
MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 24.07
ROIC/WACCN/A
WACC9.01%

2.3 Liquidity

MBLY has a Current Ratio of 5.87. This indicates that MBLY is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of MBLY (5.87) is better than 92.86% of its industry peers.
A Quick Ratio of 4.48 indicates that MBLY has no problem at all paying its short term obligations.
MBLY has a better Quick ratio (4.48) than 92.86% of its industry peers.
Industry RankSector Rank
Current Ratio 5.87
Quick Ratio 4.48

6

3. Growth

3.1 Past

The earnings per share for MBLY have decreased strongly by -55.77% in the last year.
Looking at the last year, MBLY shows a decrease in Revenue. The Revenue has decreased by -3.78% in the last year.
MBLY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.07% yearly.
EPS 1Y (TTM)-55.77%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-150%
Revenue 1Y (TTM)-3.78%
Revenue growth 3Y29.07%
Revenue growth 5YN/A
Revenue growth Q2Q-47.82%

3.2 Future

MBLY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.26% yearly.
MBLY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.62% yearly.
EPS Next Y-50.3%
EPS Next 2Y-0.79%
EPS Next 3Y14.48%
EPS Next 5Y29.26%
Revenue Next Year-8.48%
Revenue Next 2Y12.88%
Revenue Next 3Y20.3%
Revenue Next 5Y26.62%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

MBLY is valuated quite expensively with a Price/Earnings ratio of 47.63.
MBLY's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of MBLY to the average of the S&P500 Index (28.60), we can say MBLY is valued expensively.
The Price/Forward Earnings ratio is 35.85, which means the current valuation is very expensive for MBLY.
66.67% of the companies in the same industry are cheaper than MBLY, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.15. MBLY is valued rather expensively when compared to this.
Industry RankSector Rank
PE 47.63
Fwd PE 35.85

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MBLY is valued a bit more expensive than the industry average as 73.81% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, MBLY is valued a bit more expensive than 64.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 136.37
EV/EBITDA 70.86

4.3 Compensation for Growth

A more expensive valuation may be justified as MBLY's earnings are expected to grow with 14.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.79%
EPS Next 3Y14.48%

0

5. Dividend

5.1 Amount

No dividends for MBLY!.
Industry RankSector Rank
Dividend Yield N/A

MOBILEYE GLOBAL INC-A

NASDAQ:MBLY (5/17/2024, 7:12:09 PM)

After market: 28.3563 -0.22 (-0.78%)

28.58

+0.08 (+0.28%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap23.05B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 47.63
Fwd PE 35.85
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.08%
ROE -1.12%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 48.06%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 5.87
Quick Ratio 4.48
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-55.77%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-50.3%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-3.78%
Revenue growth 3Y29.07%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y